Association between the TNFα-308 A/G polymorphism and the onset-age of Alzheimer disease

被引:56
作者
Alvarez, V [1 ]
Mata, IF
González, P
Lahoz, CH
Martínez, C
Peña, J
Guisasola, LM
Coto, E
机构
[1] Hosp Cent Asturias, Genet Mol Lab, Serv Neurol, Oviedo 33006, Spain
[2] IRSIN FRIAT, Inst Invest Nefrol, Genet Mol, Oviedo, Spain
[3] Hosp Cabuenes, Serv Neurol, Gijon, Spain
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 2002年 / 114卷 / 05期
关键词
Alzheimer disease; tumor necrosis factors; DNA-polymorphisms; case-control/studies;
D O I
10.1002/ajmg.10515
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Local inflammatory processes associated with amyloid plaques would contribute to the progression of late-onset Alzheimer disease (LOAD). Tumor necrosis factors a (TNFa) and beta (LTalpha) are inflammatory cytokines involved in the local immune response occurring in the central nervous system of LOAD patients. Genetic variation at these genes could contribute to the risk of developing AD or influence the age at the onset of the disease. We genotyped 315 LOAD patients and 400 healthy controls for DNA-polymorphisms in the genes encoding TNFalpha (-308 G/ A. -238G/A) and LTa (Asn26Thr). Carriers of -308A showed a mean age at onset 3 years younger than nonearriers of this allele (P = 0.019). Our data suggest an effect of the TNFalpha-308 polymorphism on the age at onset of late AD. This represents additional evidence of the importance of genetic variation at the proinflammatory components in the origin and progression of this common neurodegenerative disease. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:574 / 577
页数:4
相关论文
共 34 条
  • [1] Impact of the-308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease
    Abraham, LJ
    Kroeger, KM
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (04) : 562 - 566
  • [2] Inflammation and Alzheimer's disease
    Akiyama, H
    Barger, S
    Barnum, S
    Bradt, B
    Bauer, J
    Cole, GM
    Cooper, NR
    Eikelenboom, P
    Emmerling, M
    Fiebich, BL
    Finch, CE
    Frautschy, S
    Griffin, WST
    Hampel, H
    Hull, M
    Landreth, G
    Lue, LF
    Mrak, R
    Mackenzie, IR
    McGeer, PL
    O'Banion, MK
    Pachter, J
    Pasinetti, G
    Plata-Salaman, C
    Rogers, J
    Rydel, R
    Shen, Y
    Streit, W
    Strohmeyer, R
    Tooyoma, I
    Van Muiswinkel, FL
    Veerhuis, R
    Walker, D
    Webster, S
    Wegrzyniak, B
    Wenk, G
    Wyss-Coray, T
    [J]. NEUROBIOLOGY OF AGING, 2000, 21 (03) : 383 - 421
  • [3] TUMOR-NECROSIS-FACTOR-ALPHA AND TUMOR-NECROSIS-FACTOR-BETA PROTECT NEURONS AGAINST AMYLOID BETA-PEPTIDE TOXICITY - EVIDENCE FOR INVOLVEMENT OF A KAPPA-B-BINDING FACTOR AND ATTENUATION OF PEROXIDE AND CA2+ ACCUMULATION
    BARGER, SW
    HORSTER, D
    FURUKAWA, K
    GOODMAN, Y
    KRIEGLSTEIN, J
    MATTSON, MP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) : 9328 - 9332
  • [4] TNFα plus IFNγ induce the production of Alzheimer β-amyloid peptides and decrease the secretion of APPs
    Blasko, I
    Marx, F
    Steiner, E
    Hartmann, T
    Grubeck-Loebenstein, B
    [J]. FASEB JOURNAL, 1999, 13 (01) : 63 - 68
  • [5] Collins JS, 2000, AM J MED GENET, V96, P823, DOI 10.1002/1096-8628(20001204)96:6<823::AID-AJMG26>3.0.CO
  • [6] 2-I
  • [7] Association between polymorphisms in the TNF region and systemic lupus erythematosus in the Italian population
    DAlfonso, S
    Colombo, G
    Della Bella, S
    Scorza, R
    MomiglianoRichiardi, P
    [J]. TISSUE ANTIGENS, 1996, 47 (06): : 551 - 555
  • [8] Grimaldi LME, 2000, ANN NEUROL, V47, P361, DOI 10.1002/1531-8249(200003)47:3<361::AID-ANA12>3.0.CO
  • [9] 2-N
  • [10] HIXSON JE, 1990, J LIPID RES, V31, P545